Research has shown that TRAIL-loaded liposomes effectively target and kill prostate circulating tumor cells (CTCs) in primary patient blood samples [120] and may systemically neutralize distant metastasis of a broad range of tumor types. The gene discussed is TNFSF10; the disease is neoplasm.